Background Malaria in pregnancy has major impacts on mother and child health. To
complement existing interventions, such as intermittent preventive treatment and use of …

The infection dynamics between different species of Plasmodium that infect the same human
host can both suppress and exacerbate disease. This could arise from inter-parasite …

Introduction: Several malaria vaccines are under various phases of development with some
promising results. In placental malaria (PM) a deliberately anti-disease approach is …

Sickle-trait hemoglobin protects against severe Plasmodium falciparum malaria. Severe
malaria is governed in part by the expression of the Plasmodium falciparum Erythrocyte …

During pregnancy, Plasmodium falciparum-infected erythrocytes (IE) accumulate in the
intervillous spaces of the placenta by binding to chondroitin sulfate A (CSA) and elicit …

While two Plasmodium falciparum circumsporozoite protein-based pre-erythrocytic vaccines
(PEV), RTS, S and R21, have been approved by the WHO, no blood-stage vaccine (BSV) or …

En Afrique sub-Saharienne, les mesures préventives contre le paludisme pendant la
grossesse ne sont mises en place qu'à partir du 2ème trimestre de la grossesse, laissant les …

Worldwide, an estimated 30 million pregnancies are at risk of malaria infection each year. In
pregnancy, Plasmodium falciparum parasites express a protein called VAR2CSA that …

Chaque année, environ 11 millions de femmes sont exposées au paludisme gestationnel
(PG) en Afrique sub-Saharienne, avec pour principales conséquences l'anémie maternelle …

Immunoepidemiology studies of malaria have historically been performed to try to identify
and understand the key targets and mechanisms of protective immunity, in order to …